Literature DB >> 20956590

Prevalence and mechanism of resistance to antimicrobial agents in group G streptococcal isolates from China.

Jun Yin1, Sangjie Yu, Xiaorong Liu, Ye Li, Wei Gao, Xiang Ma, Yonghong Yang.   

Abstract

Eighty group G streptococcal stains were collected from Chinese children. Susceptibility testing was done by a double-dilution and a disk diffusion method. PCR was used to test drug-resistant genes, and the χ(2) test and definite probability methods were used to test for statistically significant differences among the three groups. Thirty-four isolates (42.5%) showed resistance to erythromycin. There are differences between the resistance characteristics of group G streptococci from different regions of China.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20956590      PMCID: PMC3019673          DOI: 10.1128/AAC.01106-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  Different erythromycin resistance mechanisms in group C and group G streptococci.

Authors:  J Kataja; H Seppälä; M Skurnik; H Sarkkinen; P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

2.  Epidemic of pharyngitis due to streptococci of Lancefield group G.

Authors:  H R Hill; G G Caldwell; E Wilson; D Hager; R A Zimmerman
Journal:  Lancet       Date:  1969-08-16       Impact factor: 79.321

3.  Ketolides lack inducibility properties of MLS(B) resistance phenotype.

Authors:  A Bonnefoy; A M Girard; C Agouridas; J F Chantot
Journal:  J Antimicrob Chemother       Date:  1997-07       Impact factor: 5.790

4.  mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae.

Authors:  A Tait-Kamradt; J Clancy; M Cronan; F Dib-Hajj; L Wondrack; W Yuan; J Sutcliffe
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

Review 5.  Drugs of the 21st century: telithromycin (HMR 3647)--the first ketolide.

Authors:  Grit Ackermann; Arne C Rodloff
Journal:  J Antimicrob Chemother       Date:  2003-03       Impact factor: 5.790

6.  Nucleotide sequence of the gene ereA encoding the erythromycin esterase in Escherichia coli.

Authors:  H Ounissi; P Courvalin
Journal:  Gene       Date:  1985       Impact factor: 3.688

7.  Outpatient antibiotic use and assessment of antibiotic guidelines in Chinese children's hospitals.

Authors:  Wenshuang Zhang; Xuzhuang Shen; Yi Wang; Yuan Chen; Min Huang; Qiyi Zeng; Maohuai Fan; Ulf Bergman; Yonghong Yang
Journal:  Eur J Clin Pharmacol       Date:  2008-05-06       Impact factor: 2.953

8.  Infections due to Lancefield group G streptococci.

Authors:  C Vartian; P I Lerner; D M Shlaes; K V Gopalakrishna
Journal:  Medicine (Baltimore)       Date:  1985-03       Impact factor: 1.889

9.  Analysis of the nucleotide sequence of the ereB gene encoding the erythromycin esterase type II.

Authors:  M Arthur; D Autissier; P Courvalin
Journal:  Nucleic Acids Res       Date:  1986-06-25       Impact factor: 16.971

10.  Prevalence and mechanisms of erythromycin and clindamycin resistance in clinical isolates of beta-haemolytic streptococci of Lancefield groups A, B, C and G in Seville, Spain.

Authors:  L Merino Díaz; M J Torres Sánchez; J Aznar Martín
Journal:  Clin Microbiol Infect       Date:  2007-11-22       Impact factor: 8.067

View more
  2 in total

1.  Synergistic effects of antimicrobial peptide DP7 combined with antibiotics against multidrug-resistant bacteria.

Authors:  Xiaozhe Wu; Zhan Li; Xiaolu Li; Yaomei Tian; Yingzi Fan; Chaoheng Yu; Bailing Zhou; Yi Liu; Rong Xiang; Li Yang
Journal:  Drug Des Devel Ther       Date:  2017-03-22       Impact factor: 4.162

2.  Epidemiological and molecular characterization of community and hospital acquired Staphylococcus aureus strains prevailing in Shenyang, Northeastern China.

Authors:  Dan Dan Sun; Xiao Xue Ma; Jian Hu; Yuan Tian; Long Pang; Hong Shang; Long Zhu Cui
Journal:  Braz J Infect Dis       Date:  2013-07-31       Impact factor: 3.257

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.